Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) Investor files Lawsuit against Directors over alleged Wrongdoing

San Diego, CA -- (SBWIRE) -- 07/02/2012 -- A lawsuit was filed by a current investor in NASDAQ:AMLN over alleged breaches of fiduciary duties by certain directors of Amylin Pharmaceuticals, Inc. and other current long-term NASDAQ:AMLN stockholders should contact the Shareholders Foundation. Read the full press release at http://www.sbwire.com/press-releases/amylin-pharmaceuticals-inc-nasdaqamln-investor-files-lawsuit-against-directors-over-alleged-wrongdoing-150999.htm